THE IMPACT OF SUBSTANTIAL IMPROVEMENTS IN HBA1C AND WEIGHT LOSS ON THE MEDICATION PREFERENCES OF PEOPLE WITH TYPE 2 DIABETES

被引：0
|
作者：
Gelhorn, H. [1 ]
Osumili, B. [2 ]
Brown, K. [3 ]
Ross, M. [1 ]
Schulz, A. [1 ]
Fernandez, G. [1 ]
Boye, K. [4 ]
机构：
[1] Evidera, Bethesda, MD USA
[2] Eli Lilly & Co, Windlesham, Surrey, England
[3] Eli Lilly & Co, Indianapolis, IN USA
[4] EuroQol Res Fdn, Greenwood, IN USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR5
引用
收藏
页码：S312 / S313
页数：2
相关论文
共 50 条
  • [41] The management of type 2 diabetes: Is HbA1c the only goal?
    Bauduceau, B.
    Bordier, L.
    Dupuy, O.
    Garcia, C.
    Mayaudon, H.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (10): : 560 - 563
  • [42] Striking Improvements in HbA1c following Commencement of Flash Glucose Monitoring in Type 1 Diabetes
    Gibb, Fraser W.
    Stimson, Roland H.
    Mcknight, John A.
    Tyndall, Victoria
    Ritchie, Stuart A.
    Zammitt, Nicola N.
    Dover, Anna R.
    DIABETES, 2019, 68
  • [43] Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting
    Nadine Kuniss
    Ulrich A. Müller
    Christof Kloos
    Regina Müller
    Gerd Starrach
    Viktor Jörgens
    Guido Kramer
    Acta Diabetologica, 2018, 55 : 131 - 137
  • [44] Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting
    Kuniss, Nadine
    Mueller, Ulrich A.
    Kloos, Christof
    Mueller, Regina
    Starrach, Gerd
    Joergens, Viktor
    Kramer, Guido
    ACTA DIABETOLOGICA, 2018, 55 (02) : 131 - 137
  • [45] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1512 - 1522
  • [46] THE RELATIONSHIP BETWEEN POOR ADHERENCE AND HBA1C AND WEIGHT CHANGES IN PATIENTS WITH TYPE 2 DIABETES
    Ramos, M.
    Foos, V
    Ferrufino, C.
    Yu-Isenberg, K.
    Lamotte, M.
    VALUE IN HEALTH, 2018, 21 : S138 - S138
  • [47] Distinct HbA1c trajectories in a type 2 diabetes cohort
    Walraven, Iris
    Mast, M. Ruth
    Hoekstra, Trynke
    Jansen, A. P. Danielle
    van der Heijden, Amber A. W. A.
    Rauh, Simone P.
    Rutters, Femke
    van't Riet, Esther
    Elders, Petra J. M.
    Moll, Annette C.
    Polak, Bettine C. P.
    Dekker, Jacqueline M.
    Nijpels, Giel
    ACTA DIABETOLOGICA, 2015, 52 (02) : 267 - 275
  • [48] Distinct HbA1c trajectories in a type 2 diabetes cohort
    Iris Walraven
    M. Ruth Mast
    Trynke Hoekstra
    A. P. Danielle Jansen
    Amber A. W. A. van der Heijden
    Simone P. Rauh
    Femke Rutters
    Esther van ’t Riet
    Petra J. M. Elders
    Annette C. Moll
    Bettine C. P. Polak
    Jacqueline M. Dekker
    Giel Nijpels
    Acta Diabetologica, 2015, 52 : 267 - 275
  • [49] HbA1c and the Prediction of Type 2 Diabetes in Children and Adults
    Vijayakumar, Pavithra
    Nelson, Robert G.
    Hanson, Robert L.
    Knowler, William C.
    Sinha, Madhumita
    DIABETES CARE, 2017, 40 (01) : 16 - 21
  • [50] Worsening of HbA1c but not of body weight during ten years in a type 2 diabetes population
    Fornengo, P
    Bruno, A
    Ferrero, L
    Pagano, G
    DIABETES, 1999, 48 : A82 - A83
12345